A practical reference on LC-MS/MS: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-06-10. Anything still debated is marked as such rather than presented as settled.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Common supplier description |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water |
| Typical storage | −20 °C, desiccated, dark | For research samples |
| Analytical method | LC-MS/MS | Used for detection and quantification |
| Regulatory status | Prohibited in sport | WADA metabolic modulator class |
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
In September 2025, following an Israeli strike against suspected Hamas terrorists in Qatar's capital city of Doha, President Trump signed an executive order which stated, "The United States shall regard any armed attack on the territory, sovereignty, or critical infrastructure of the State of Qatar as a threat to the peace and security of the United States." President Biden had begun a closer relationship with Qatar following their help with the 2001 American withdrawal from Afghanistan. In January 2022, Biden named Qatar a major non-NATO ally. The editorial board of The Wall Street Journal wrote, "This is a decision that can be and should have been debated. Instead it comes out of the blue — an executive order following no public debate." In October, Defense Secretary Hegseth announced a training agreement that the Qatar Air Force will build a facility at the Mountain Home Air Force Base in Idaho. The United States has a similar arrangement with Singapore, at the same base. Hegseth emphasized that the U.S. will remain in charge of the facility "like we do with all partners".
== Cause == A seroma is usually caused by surgery. Seromas are particularly common after breast surgery (e.g., mastectomy), abdominal surgery, and reconstructive surgery. It can also be seen after neck surgery, thyroid and parathyroid surgery, and hernia repair. The larger the surgical intervention, the more likely that seromas form. Early or improper removal of sutures can sometimes lead to formation of seroma or discharge of serous fluid from operative areas. Seromas can also sometimes be caused by injury, such as when the initial swelling from a blow or fall does not fully subside. The remaining serous fluid causes a seroma that the body usually absorbs gradually over time (often taking many days or weeks), but a knot of calcified tissue sometimes remains. Large seromas take longer to resolve than small ones, and they are more likely to undergo secondary infection. A seroma may persist for several months, or even years as the surrounding tissue hardens. Seroma is the most common surgical complication after breast surgery. It is due to the presence of rich lymphatic system in the breast, low fibrinogen levels in lymph fluid and potential space creation in the breast after surgery, which contributes to seroma formation. Seroma is more common in older and obese people.
==== Diverse food sourcing ==== Diverse sourcing of food, such as through international trade, is a key strategy for building agrifood systems' resilience because it buffers the food supply against shocks and stresses. The volume of agrifood trade more than doubled between 2000 and 2024. Although international trade buffers against domestic shocks, it increases exposure to external shocks and can itself become a channel of shock transmission, therefore having diverse international trade partners is key. Enhancing diversity in terms of commodities is also essential for ensuring the supply of food necessary for healthy diets. However, evidence on the diversity of food supply in terms of domestic production, imports and stocks reveal that the potential of international trade is not equally well exploited in all countries. Low-income countries, such as in sub-Saharan Africa, are among those with the lowest diversity of imports as the food supply is mostly determined by what is produced for the domestic market.
Sources: en.wikipedia.org
=== United States === The first country to have TPMS mandatory was the United States of America. In the early 2000s, numerous traffic accidents such as rollovers and tire blowouts occurred due to insufficient air pressure level. NHTSA regarded flat tires as a potential threat to safety which was soon followed by the enactment of Federal Motor Vehicle Safety Standard 138 on attaching TPMS for every vehicle by September 2007, phased in from 2005. The standard is to warn drivers of significant under-inflation of tires and the resulting safety problems of low tire pressure. This standard requires TPMS to be installed in all new passenger cars, multipurpose passenger vehicles, trucks, and buses that have a gross vehicle weight rating (GVWR) of 4,536 kg (10,000 lbs.) or less, except those vehicles with dual wheels on an axle. The final rule requires that the driver be given a warning when tire pressure is 25 percent or more below the vehicle manufacturer's recommended cold tire inflation pressure (placard pressure) for one to four tires.
=== Russia === Russia had plans to ban powdered alcohol in 2016. According to one Russian news site, in 2009, a professor at Saint Petersburg Technological University named Yevgeny Moskalev invented and patented a method of creating alcohol powder. This method could make alcohol powder from any kind of alcoholic beverage.
NatB acetylates N-terminal proteins starting with methionine (iMet) followed by or amidic amino acids, making the target pool to be MD, ME, MN and MQ. Almost 100% of all the proteins that are target substrates of NatB are N-terminally acetylated, which is a unique feature of NatB compared to other NATs. Finding substrates and proteins that are N-terminally acetylated by NatB has been studied in yeast and humans in order to understand the biological function of NatB. In yeast, lack of N-terminal acetylation activity by NatB has an effect on actin and tropomyosin interactions. The NF-κB subunit p65 has also been proposed to be a target protein in humans, as well as tropomyosin 1. NatB also seems to potentially regulate the Set-COMPASS subunit protein Swd1 by N-terminal acetylation, and therefore NatB could regulate H3K4 methylation together with NatA. NatB might also regulate NAD+ metabolism in yeast, where knockout of nat3Δ (NAA25) and mdm20Δ (NAA20) decreased the levels of the nicotinamide mononucleotide adenylyltransferase (Nmnat) proteins Nma1 and Nma2. NATs belongs to the GCN5 related N-acetyltransferases (GNAT) superfamily. N-terminal acetylation is the process of adding an acetyl group during or after protein synthesis.
=== Structural domains === All of the isoforms of CaMKII have: a catalytic domain, an autoinhibitory regulatory domain, a variable segment, and a self-association domain. The catalytic domain binds ATP and substrate proteins; it is responsible for the transfer of phosphate from ATP to Ser or Thr residues in the substrate proteins. The autoinhibitory regulatory domain features a pseudosubstrate site, which binds to the catalytic domain and blocks its ability to phosphorylate proteins. The structural feature that governs this autoinhibition is the Threonine 286 residue. Phosphorylation of this site will permanently activate the CaMKII enzyme. Once the Threonine 286 residue has been phosphorylated, the inhibitory domain is blocked from the pseudosubstrate site. This effectively blocks autoinhibition, allowing for permanent activation of the CaMKII enzyme. This enables CaMKII to be active, even in the absence of calcium and calmodulin. The other two domains in CaMKII are the variable and self-association domains. Differences in these domains contribute to the various CaMKII isoforms. The self-association domain (CaMKII AD) is found at the C terminus, the function of this domain is the assembly of the single proteins into large (8 to 14 subunits) multimers.
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is sold as a research chemical, but sports and medicine regulations restrict it.
Detection commonly uses liquid chromatography–tandem mass spectrometry. This method can identify the compound in urine or blood at low concentrations.
Typical guidance is −20 °C, dry, and protected from light. Solutions should be aliquoted and limited freeze–thaw cycles should be used.
SR9009 is a synthetic research compound that binds and modulates the nuclear receptors REV-ERBα and REV-ERBβ. It is used in laboratory studies of circadian biology and metabolism, not as an approved medicine. It is also known by the informal name Stenabolic.